SELLAS Life Sciences Group Ownership | Who Owns SELLAS Life Sciences Group?


OverviewForecastFinancialsChart

SELLAS Life Sciences Group Ownership Summary


SELLAS Life Sciences Group is owned by 9.05% institutional investors, 0.24% insiders, and 90.70% retail investors. Vanguard group is the largest institutional shareholder, holding 3.99% of SLS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.63% of its assets in SELLAS Life Sciences Group shares.

SLS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSELLAS Life Sciences Group9.05%0.24%90.70%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.79M3.99%$2.13M
Alyeska investment group1.48M3.30%$1.76M
Geode capital management517.01K1.15%$615.33K
Blackrock430.37K0.96%$512.14K
Opus capital group221.00K0.49%$263.00K
Equitable210.00K0.47%$249.90K
Diametric capital, lp153.02K0.34%$182.09K
Millennium management150.45K0.34%$179.03K
State street134.03K0.30%$159.50K
Northern trust100.84K0.23%$120.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Diametric capital, lp153.02K0.10%$182.09K
Opus capital group221.00K0.04%$263.00K
Alyeska investment group1.48M0.01%$1.76M
Virtu financial63.84K0.01%$76.00K
Prelude capital management55.73K0.00%$66.31K
Equitable210.00K0.00%$249.90K
Nemes rush group10.00K0.00%$11.90K
Tower research capital llc (trc)13.63K0.00%$16.22K
Mariner44.93K0.00%$53.47K
Renaissance32.45K0.00%$38.61K

Top Buyers

HolderShares% AssetsChange
Alyeska investment group1.48M0.01%479.07K
Vanguard group1.79M-273.10K
Geode capital management517.01K0.00%243.94K
Diametric capital, lp153.02K0.10%153.02K
Blackrock430.37K-152.15K

Top Sellers

HolderShares% AssetsChange
Anson funds management lp---4.83M
Prosperity financial group---25.39K
Cantor fitzgerald, l. p.---24.75K
Citadel advisors---19.72K
Xtx topco---17.39K

New Positions

HolderShares% AssetsChangeValue
Diametric capital, lp153.02K0.10%153.02K$182.09K
Prelude capital management55.73K0.00%55.73K$66.31K
Lpl financial51.89K-51.89K$61.75K
Jane street group27.99K-27.99K$33.31K
Belvedere trading12.70K-12.70K$15.11K

Sold Out

HolderChange
Fmr-1.00
Qube research-2.00
Allworth financial lp-150.00
Wells fargo & company/mn-301.00
Jpmorgan chase-6.09K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024356.06%4,057,046-47.43%91.57%2460.00%2-66.67%
Mar 31, 202433-7,717,107121.72%2415.94%15-25.00%620.00%
Dec 31, 20233313.79%3,480,63027.06%1213.15%2042.86%5-
Sep 30, 20232911.54%2,739,264-11.69%95.57%1427.27%525.00%
Jun 30, 202326-3.70%3,101,725-35.40%133.17%11-8.33%4-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.69M2.63%-
Vanguard Institutional Extnd Mkt Idx Tr501.97K0.78%-
Fidelity Extended Market Index318.42K0.49%-1.29K
iShares Micro-Cap ETF131.65K0.20%-
Fidelity Total Market Index119.59K0.19%52.13K
BlackRock Extended Equity Market K100.56K0.16%-43.00
Fidelity Series Total Market Index85.89K0.13%28.20K
Vanguard Instl Ttl Stk Mkt Idx InstlPls66.67K0.10%-
Northern Trust Extended Eq Market Idx60.52K0.09%-
NT Ext Equity Mkt Idx Fd - L60.52K0.09%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2022Stergiou Angelos M. President and CEOSell$16.94K
Dec 05, 2022Burns John Thomas Senior VP, Finance & CAOSell$3.00K
Dec 05, 2022WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec.Sell$5.58K
Dec 02, 2021Stergiou Angelos M. President and CEOSell$13.25K
Dec 02, 2021WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec.Sell$5.30K

Insider Transactions Trends


DateBuySell
2023 Q4--
2023 Q1--
2022 Q4-3
2022 Q3--
2022 Q1--

SLS Ownership FAQ


Who Owns SELLAS Life Sciences Group?

SELLAS Life Sciences Group shareholders are primarily institutional investors at 9.05%, followed by 0.24% insiders and 90.71% retail investors. The average institutional ownership in SELLAS Life Sciences Group's industry, Biotech Stocks , is 45.43%, which SELLAS Life Sciences Group falls below.

Who owns the most shares of SELLAS Life Sciences Group?

SELLAS Life Sciences Group’s largest shareholders are Vanguard group (1.79M shares, 3.99%), Alyeska investment group (1.48M shares, 3.30%), and Geode capital management (517.01K shares, 1.15%). Together, they hold 8.44% of SELLAS Life Sciences Group’s total shares outstanding.

Does Blackrock own SELLAS Life Sciences Group?

Yes, BlackRock owns 0.96% of SELLAS Life Sciences Group, totaling 430.37K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 512.14K$. In the last quarter, BlackRock increased its holdings by 152.15K shares, a 54.69% change.

Who is SELLAS Life Sciences Group’s biggest shareholder by percentage of total assets invested?

Diametric capital, lp is SELLAS Life Sciences Group’s biggest shareholder by percentage of total assets invested, with 0.10% of its assets in 153.02K SELLAS Life Sciences Group shares, valued at 182.09K$.

Who is the top mutual fund holder of SELLAS Life Sciences Group shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SELLAS Life Sciences Group shares, with 2.63% of its total shares outstanding invested in 1.69M SELLAS Life Sciences Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools